Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.170
-0.120 (-2.80%)
Dec 26, 2025, 9:58 AM EST - Market open
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $100.38 million as of December 26, 2025. Its market cap has increased by 119.92% in one year.
Market Cap
100.38M
Enterprise Value
87.53M
1-Year Change
119.92%
Ranking
Category
Stock Price
$4.17
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $100.38M, a decrease of -88.26%. That is a compound annual growth rate of -27.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 103.27M | 253.33% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | 437.69M | -37.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |